Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment

B. Strober, M. Buonanno, J. D. Clark, T. Kawabata, H. Tan, R. Wolk, H. Valdez, R. G. Langley, J. Harness, A. Menter, K. Papp

Research output: Contribution to journalArticlepeer-review

85 Citations (Scopus)
Original languageEnglish
Pages (from-to)992-999
Number of pages8
JournalBritish Journal of Dermatology
Volume169
Issue number5
DOIs
Publication statusPublished - Nov 2013

ASJC Scopus Subject Areas

  • Dermatology

Fingerprint

Dive into the research topics of 'Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment'. Together they form a unique fingerprint.

Cite this